Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$136.52 USD

136.52
7,975,199

+7.51 (5.82%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $137.20 +0.68 (0.50%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (46 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.

Zacks Equity Research

Civitas Solutions (CIVI) Extends ADH Platform to New Jersey

by Zacks Equity Research

Civitas Solutions, Inc. (CIVI) recently announced that it has expanded its platform of Adult Day Health services to the state of New Jersey.

    Zacks Equity Research

    Medtronic Resource Centre Opens for Diabetic People in Canada

    by Zacks Equity Research

    Medtronic plc (MDT) announced that its subsidiary has opened its first Canadian Medtronic Resource Centre to serve diabetic patients in Surrey BC and nearby.

      Zacks Equity Research

      Hill-Rom Rides High on Solid Prospects, Asia-Pacific a Drag

      by Zacks Equity Research

      On Jun 11, we issued an updated research report on Batesville, IN-based Hill-Rom Holdings, Inc. (HRC) -- a leading global medical device company.

        Zacks Equity Research

        FDA Passes Zimmer Biomet's (ZBH) Zhejiang Facility Issue

        by Zacks Equity Research

        Zimmer Biomet Holdings, Inc. (ZBH) revealed that the U.S. Food and Drug Administration (FDA) has closed out its 'Warning Letter' related to the company's Zhejiang, China manufacturing facility.

          Zacks Equity Research

          Becton (BDX) with FlowJo to Provide Cloud Platform Services

          by Zacks Equity Research

          Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has entered into an agreement with FlowJo, LLC.

            Zacks Equity Research

            Mead Johnson-Reckitt Move to Merge, Deal Closes on Jun 15

            by Zacks Equity Research

            Mead Johnson Nutrition Company (MJN) and Reckitt Benckiser have cleared the final regulatory hurdle of their impending merger.

              Zacks Equity Research

              PetMed Express' New Order Sales Increase, Competition Rife

              by Zacks Equity Research

              On Jun 12, we issued an updated research report on Pompano Beach, FL-based PetMed Express, Inc. (PETS).

                Zacks Equity Research

                Quest Diagnostics to Buy 2 Labs, Grow in Oncology Space

                by Zacks Equity Research

                Quest Diagnostics (DGX) recently announced agreements to acquire two laboratory businesses in Lewisville, Texas, namely Med Fusion and Clear Point.

                  Zacks Equity Research

                  Phibro Animal Health (PAHC) Rides High on Solid Prospects

                  by Zacks Equity Research

                  On Jun 12, we issued an updated research report on NJ-based Phibro Animal Health Corporation (PAHC) ??? a leading global diversified animal health and mineral nutrition company.

                    Zacks Equity Research

                    Luminex's (LMNX) VERIGENE Panels Receive Approval in Japan

                    by Zacks Equity Research

                    Luminex Corporation (LMNX) recently announced that Japan's Central Social Insurance Medical Council has approved to provide reimbursement for VERIGENE assays.

                      Zacks Equity Research

                      Will Walgreens-Rite Aid Deal Fall Flat on FTC Blockade?

                      by Zacks Equity Research

                      Walgreens Boots Alliance, Inc. (WBA) stock took a marginal hit of 0.6% on Friday's close, following the news breakout that the FTC is blocking the impending Rite Aid merger deal.

                        Zacks Equity Research

                        Masimo (MASI) Presents Utility Study of Oxygen Reserve Index

                        by Zacks Equity Research

                        Masimo Corporation (MASI) recently announced data from its study evaluating the potential clinical utility of Masimo Oxygen Reserve Index.

                          Zacks Equity Research

                          NuVasive (NUVA) at 52-Week High: What's Driving the Stock?

                          by Zacks Equity Research

                          Share price of NuVasive, Inc. (NUVA) scaled a new 52-week high of $81.06 on Jun 9, eventually closing a bit lower at $79.13.

                            Zacks Equity Research

                            Cardiovascular Systems (CSII) Hits 52-Week High on Solid Q3

                            by Zacks Equity Research

                            Share price of Cardiovascular Systems, Inc. (CSII) scaled a new 52-week high of $32.68 on Jun 9, eventually closing a bit lower at $30.93.

                              Zacks Equity Research

                              Medtronic Launches MiniMed 670G to Better Manage Diabetes

                              by Zacks Equity Research

                              Medtronic plc (MDT) commercially launched MiniMed 670G system, a Hybrid Closed Loop insulin delivery system for Type I diabetic patients.

                                Zacks Equity Research

                                Invacare (IVC) Prices $105 Million Convertible Senior Notes

                                by Zacks Equity Research

                                Invacare Corporation (IVC) recently announced that it has priced convertible senior notes worth $105 million.

                                  Zacks Equity Research

                                  CVS Health Gains on Pharmacy Services, Strategic Buyouts

                                  by Zacks Equity Research

                                  On Jun 8, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS).

                                    Zacks Equity Research

                                    Hologic Wins FDA Approval for Genius 3D Mammography Exam

                                    by Zacks Equity Research

                                    Hologic, Inc. (HOLX) continues to expand its Breast and Skeletal Health business through innovation and product development.

                                      Zacks Equity Research

                                      Zimmer Biomet Rides on Spine Business, Knee Challenges Stay

                                      by Zacks Equity Research

                                      On Jun 6, we issued an updated research report on Warsaw, IN-based Zimmer Biomet Holdings Inc. (ZBH).

                                        Zacks Equity Research

                                        Bruker Grows on NMR & Nano Businesses amid Several Odds

                                        by Zacks Equity Research

                                        On Jun 6, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR), a manufacturer of proprietary life science and materials research systems.

                                          Zacks Equity Research

                                          Boston Scientific Wins CE Mark for Vercise Gevia DBS System (revised)

                                          by Zacks Equity Research

                                          Generally, DBS therapy is a surgical procedure of placing a device that stimulates specific areas in the brain using electrical signals.

                                            Zacks Equity Research

                                            Cardiovascular Systems Innovation On Track, Competition Rife

                                            by Zacks Equity Research

                                            On Jun 6, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).

                                              Zacks Equity Research

                                              Here's Why You Should Bet on Humana (HUM) Stock Right Now

                                              by Zacks Equity Research

                                              Louisville-based Humana Inc. (HUM), one of the largest health care plan providers in the United States, has been an investor favorite, given its strong fundamentals

                                                Zacks Equity Research

                                                Medtronic SureTune3 Obtains Health Canada License for DBS

                                                by Zacks Equity Research

                                                Medtronic plc (MDT) recently announced the receipt of Health Canada license for SureTune 3 software for deep brain stimulation (DBS).

                                                  Zacks Equity Research

                                                  Boston Scientific Wins CE Mark for Vercise Gevia DBS System

                                                  by Zacks Equity Research

                                                  Boston Scientific Corporation (BSX) recently won CE mark for its Vercise Gevia Deep Brain Stimulation (DBS) System.